These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27545830)

  • 21. Occurrence of Diverse Antimicrobial Resistance Determinants in Genetically Unrelated Biocide Tolerant Klebsiella pneumoniae.
    Mondal A; Venkataramaiah M; Rajamohan G; Srinivasan VB
    PLoS One; 2016; 11(11):e0166730. PubMed ID: 27870879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.
    Singh SK; Gupta M
    Microb Pathog; 2016 Nov; 100():75-77. PubMed ID: 27622347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
    Roy S; Viswanathan R; Singh AK; Das P; Basu S
    J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155
    [No Abstract]   [Full Text] [Related]  

  • 24. [Emerging and drug-resistant infections diseases--ESBL producing bacterial infections].
    Okamoto R; Inoue M
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2081-7. PubMed ID: 9480314
    [No Abstract]   [Full Text] [Related]  

  • 25. Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.
    Padmini N; Ajilda AAK; Sivakumar N; Selvakumar G
    J Basic Microbiol; 2017 Jun; 57(6):460-470. PubMed ID: 28397262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of antimicrobial resistance and extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains from infected neonates.
    Aktas E; Yigit N; Yazgi H; Ayyildiz A
    J Int Med Res; 2002; 30(4):445-8. PubMed ID: 12235930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
    Ahmad S; Al-Juaid NF; Alenzi FQ; Mattar EH; Bakheet Oel-S
    J Coll Physicians Surg Pak; 2009 Apr; 19(4):264-5. PubMed ID: 19356348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
    Chung KP; Tseng SP; Huang YT; Tsai TH; Teng LJ; Hsueh PR
    J Antimicrob Chemother; 2011 May; 66(5):1182-4. PubMed ID: 21393195
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
    Kritsotakis EI; Tsioutis C; Roumbelaki M; Christidou A; Gikas A
    J Antimicrob Chemother; 2011 Jun; 66(6):1383-91. PubMed ID: 21454344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of hydrolytic properties of SHV-2 and SHV-1 beta-lactamases, particularly concerning third-generation cephalosporins.
    Labia R; Tiwari K; Morand A; Mattioni D; Yaghlane HB; Redjeb SB; Boujenah A
    J Chemother; 1989 Jul; 1(4 Suppl):329-30. PubMed ID: 16312425
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug resistance of extended-spectrum-β-lactamases-producing bacteria in children with hematological malignancy after chemotherapy].
    Zheng ZJ; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):518-20. PubMed ID: 22809605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM
    Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
    [No Abstract]   [Full Text] [Related]  

  • 36. [Extended-spectrum beta-lactamase production and antimicrobial resistance patterns of Klebsiella pneumoniae strains isolated from nosocomial bacteremic patients: evaluation of the results of 2001-2005 period].
    Taşbakan MI; Pullukçu H; Sipahi OR; Aydemir S; Arda B; Yamazhan T; Tunger A; Ulusoy S
    Mikrobiyol Bul; 2008 Jan; 42(1):1-7. PubMed ID: 18444557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro antimicrobial susceptibilities and beta-lactamase production of clinical isolates. beta-Lactamase Study Group in Chubu-area].
    Ito Y; Kanematsu M; Yura J; Ueno K; Watanabe K
    Jpn J Antibiot; 1994 Jan; 47(1):11-21. PubMed ID: 8114269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of CTX-M type beta-lactamases in Klebsiella pneumoniae clinical isolates by phenotypic and molecular methods].
    Tikveşli S; Cevahir N; Kaleli I
    Mikrobiyol Bul; 2009 Oct; 43(4):553-62. PubMed ID: 20084908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.